HOME >> MEDICINE >> NEWS
Studies demonstrate positive data in treatment of hepatitis C

BOSTON Data from two ongoing studies testing new approaches for the treatment of chronic hepatitis C will be presented at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) this afternoon.

Presented by principal investigator Nezam Afdhal, M.D., Chief of Hepatology at Beth Israel Deaconess Medical Center (BIDMC) and Associate Professor of Medicine at Harvard Medical School, the new findings provide researchers with sufficient evidence to demonstrate promising results for hepatitis C patients who have not responded to existing therapies.

A viral infection, hepatitis C is transmitted through exposure to infected blood. The virus, which affects an estimated 4 million individuals nationwide, is able to survive and flourish inside the body by taking up residence in the liver cells, and subsequently using the cells' inner machinery to make more copies of the virus. These in turn, infect other healthy cells.

The standard treatment for hepatitis C is a combination of interferon alfa and ribavirin, which act as anti-viral agents to eradicate the virus. According to Afdhal, the most recent advance in treatment has been the pegylation of interferon, which enables a once- a- week administration of the protein by injection and improves the ability to clear the virus. Combination therapy with pegylated interferon plus ribavirin for 24 to 48 weeks can result in eradication of the virus in about 50 percent of patients, he adds.

"When the hepatitis C virus doesn't respond as occurs in about half of all patients who are treated those patients who already have cirrhosis are at a far greater risk for developing liver cancer or suffering liver failure," notes Afdhal. In fact, he says, hepatitis C is the leading cause of liver transplants in the U.S. Until now, no treatment has been available for these patients.

In his first presentation, Afdhal will describe results from the COPILOT [Colchicine versus PEG-INTRON Long-Term
'"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
1-Nov-2004


Page: 1 2 3

Related medicine news :

1. Studies underscore genetic involvement in nicotine addiction & aggressive hostility
2. Studies address issues of risk and survival in rapidly increasing GI cancers
3. Studies examine coffee drinking and risk of liver and colorectal cancers
4. Studies reveal physicians attitudes on end-of-life care
5. Studies from the November issue of The Archives of Dermatology, a theme issue on facial rejuvenation
6. Studies link obesity to increased frequency of heartburn symptoms; greater risk of esophageal cancer
7. Studies examine risk factors and potential consequences associated with prehypertension
8. Studies show ACTOS(R) (pioglitazone HCl) has positive effects on various components of dyslipidemia
9. Studies identify risk factors for colon cancer
10. Studies indicate healthy eating may affect cancer development, improve digestive system
11. Studies compare hysterectomy vs. other medical treatments for abnormal uterine bleeding

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2018)... ... November 09, 2018 , ... The event takes place on Wednesday, November 14, ... The Memory Care was recently updated because of the generous supporters of Eskaton Foundation. ... with dementia. “Dementia is a feared word in today’s society and is often misunderstood,” ...
(Date:11/9/2018)... SAN FRANCISCO (PRWEB) , ... November 09, 2018 ... ... the leader in microbial genomics, has awarded microbiome research support in study design, ... Spain led by Dr. Isabel Sospedra, PhD, to study the effects of a ...
(Date:11/9/2018)... ... 08, 2018 , ... Chapters Health System and ... LifePath Hospice ) announced today Dean H. Forman, MBA, will start officially as ... directly to President and Chief Executive Officer Andrew Molosky. In 2017, Chapters Health ...
(Date:11/8/2018)... ... November 08, 2018 , ... ... reported among different media sources could impact how they view advertising and earned ... (FMMS). Market Connections, Inc. will release results of the tenth annual study of ...
(Date:11/8/2018)... PASS, Ore. (PRWEB) , ... November 08, 2018 , ... ... in celebration of Breast Cancer Awareness Month. For each custom “Be Aware” mug sold ... , “We are so proud of the support our customers showed for these ...
Breaking Medicine News(10 mins):
(Date:11/9/2018)... ... , ... After just more than a year in business, ... – Caring Transitions of Cleveland Western Suburbs – to include the east side ... will now be doing business as Caring Transitions of Cleveland Western Suburbs and ...
(Date:11/8/2018)... ... November 08, 2018 , ... Health Velocity Capital ... affiliated funds with more than $185 million in committed capital. The fund ... helping to build innovative healthcare software and services businesses that contribute to a ...
(Date:11/8/2018)... ... November 08, 2018 , ... From November 1 to December 31, the ... to the Alamo Breast Cancer Foundation. “Cancer is a nightmare,” said Gloria Gonzales, broker ... the imagination can really capture it. When it happens to you, then you know. ...
Breaking Medicine Technology:
Cached News: